Capricor Therapeutics Inc (CAPR)
5.24
-0.09
(-1.69%)
USD |
NASDAQ |
May 02, 16:00
5.23
-0.01
(-0.19%)
After-Hours: 20:00
Capricor Therapeutics Revenue (Quarterly): 12.09M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.09M |
| September 30, 2023 | 6.186M |
| June 30, 2023 | 3.918M |
| March 31, 2023 | 2.987M |
| December 31, 2022 | 0.9599M |
| September 30, 2022 | 1.592M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 0.2041M |
| March 31, 2021 | 0.0408M |
| December 31, 2020 | 0.0578M |
| September 30, 2020 | 0.0169M |
| June 30, 2020 | 0.0499M |
| March 31, 2020 | 0.1857M |
| December 31, 2019 | 0.2221M |
| September 30, 2019 | 0.1421M |
| June 30, 2019 | 0.4104M |
| March 31, 2019 | 0.2305M |
| December 31, 2018 | 0.6481M |
| September 30, 2018 | 0.2192M |
| June 30, 2018 | 0.404M |
| March 31, 2018 | 0.4001M |
| December 31, 2017 | 0.4758M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.3133M |
| June 30, 2017 | 0.9965M |
| March 31, 2017 | 0.8808M |
| December 31, 2016 | 0.6836M |
| September 30, 2016 | 0.6836M |
| June 30, 2016 | 0.9115M |
| March 31, 2016 | 0.9115M |
| December 31, 2015 | 0.9115M |
| September 30, 2015 | 0.9115M |
| June 30, 2015 | 0.9115M |
| March 31, 2015 | 1.042M |
| December 31, 2014 | 1.042M |
| September 30, 2014 | 1.042M |
| June 30, 2014 | 1.042M |
| March 31, 2014 | 1.042M |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | -0.1955M |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 0.1955M |
| December 31, 2011 | 0.1955M |
| September 30, 2011 | 0.813M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0169M
Minimum
Sep 2020
12.09M
Maximum
Dec 2023
1.937M
Average
0.2221M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Cutera Inc | 49.54M |
| Sarepta Therapeutics Inc | 413.46M |
| PTC Therapeutics Inc | 210.12M |
| Solid Biosciences Inc | -- |
| AIM ImmunoTech Inc | 0.065M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.7621M |
| Total Expenses (Quarterly) | 13.37M |
| EPS Diluted (Quarterly) | 0.02 |
| Enterprise Value | 125.59M |
| Profit Margin (Quarterly) | -6.30% |
| Earnings Yield | -15.84% |
| Normalized Earnings Yield | -17.07 |